Amrutanjan Health Care Ltd

Amrutanjan Health Care Investor Presentation: Key Takeaways

Q2 FY27 net sales ₹135.2 Cr (+14.9%), PAT ₹17.3 Cr (+23.8%). H1 PAT ₹21.7 Cr, down 2.8% on cost pressure.

Amrutanjan Health Care Dividend

Amrutanjan Health Care set November 7, 2026 as the record date for its first FY2026-27 interim dividend. The dividend amount per share is not stated.

Amrutanjan Health Care Q2 FY27 Results: Net Profit ₹17.3 Cr, Up 23.6% YoY

Amrutanjan Health Care Ltd reported revenue from operations of ₹135.2 Cr (+14.9% YoY) and net profit of ₹17.3 Cr (+23.6% YoY) for Q2 FY27.

Key figure

Net profit ₹17.3 Cr · +23.6% YoY

Amrutanjan Health Care Board Meeting Date

Amrutanjan Health Care scheduled its board meeting for 3 Nov 2026 to consider Q2/H1 results and 1st interim dividend. No financial figures or dividend amount are stated in this advance intimation.

Amrutanjan Health Care Other Announcement

Amrutanjan Health Care received a voluntary CRISIL ESG rating of 'Adequate' (score 60). No capital or operational impact arises from this rating.

Amrutanjan Health Care Annual General Meeting

Amrutanjan Health Care Limited held its 89th AGM on September 23, 2026. The meeting transacted business including the adoption of accounts, dividend declaration, and director re-appointment.

Amrutanjan Health Care Annual General Meeting

Amrutanjan Health Care Limited has issued a notice for its 89th Annual General Meeting on September 23, 2026. Key agenda items include adopting financial statements and declaring a final dividend of Rs. 2.90 per share.

Amrutanjan Health Care Annual General Meeting

Amrutanjan Health Care Limited has issued a notice for its 89th Annual General Meeting on September 23, 2026. Key agenda items include adopting financial statements and declaring a final dividend.

Value

₹0.06 Cr

Amrutanjan Health Care Business Update

Amrutanjan Health Care Limited submitted its Business Responsibility and Sustainability Report (BRSR) for FY 2025-26. This disclosure forms part of the company's Annual Report requirements.

Amrutanjan Health Care Annual Report

Amrutanjan Health Care Limited submitted its 89th Annual Report for the financial year 2025-26. The company scheduled its Annual General Meeting for September 23, 2026.

Amrutanjan Health Care Investor Presentation: Key Takeaways

Amrutanjan reported 9.48% revenue growth in Q1 FY27, driven by Women's Hygiene (21%) and Beverages (11.34%). Profitability was hit by a one-time INR 2.02 Cr lease rent provision.

Call

Guides 10% growth

Amrutanjan Health Care Dividend

Amrutanjan Health Care Limited has fixed September 11, 2026, as the record date for the payment of the final dividend for the financial year 2025-26.

Amrutanjan Health Care Q1 FY27 Results: Net Profit ₹4.4 Cr, Down 47.0% YoY

Amrutanjan Health Care Ltd reported revenue from operations of ₹103 Cr (+9.6% YoY) and net profit of ₹4.4 Cr (-47.0% YoY) for Q1 FY27.

Key figure

Net profit ₹4.4 Cr · -47.0% YoY

Amrutanjan Health Care Other Announcement

Amrutanjan Health Care Ltd explained a delay in filing a credit rating disclosure due to the unavailability of the Key Managerial Personnel.

Amrutanjan Health Care Board Meeting Date

Amrutanjan Health Care Limited has scheduled a Board meeting on August 11, 2026, to consider and approve the unaudited financial results for the quarter ended June 30, 2026.

Amrutanjan Health Care Production Started

Amrutanjan Health Care has commenced commercial operations at its new Greenfield Sanitary Napkin Manufacturing Facility in Telangana. This marks a significant manufacturing capacity expansion.

Amrutanjan Health Care Production Started

Amrutanjan Health Care has commissioned a new ₹150 crore greenfield sanitary napkin manufacturing facility in Telangana. The plant features a 700 million annual unit capacity.

Value

₹150.0 Cr

Amrutanjan Health Care Credit Rating

CARE Ratings has assigned a 'CARE A; Stable' issuer rating to Amrutanjan Health Care Limited. The rating reflects the company's established brand and debt-free capital structure.

Amrutanjan Health Care Capital Structure Change

DSP Mutual Fund schemes sold 2,11,361 shares of Amrutanjan Health Care Limited in the open market. This transaction reduced their stake from 3.55% to 2.82%.

Amrutanjan Health Care Legal & Regulatory

Amrutanjan Health Care paid ₹9.75 Crore as lease rent arrears to Kapaleeswarar Temple, complying with a Madras High Court order.

Value

₹9.75 Cr

Amrutanjan Health Care Legal & Regulatory

Amrutanjan Health Care filed a SEBI DP Regulation 74(5) compliance certificate confirming dematerialisation and cancellation of securities for Q1 2026. No financial impact.

Amrutanjan Health Care Other Announcement

Mr. Ramaswami Krishnan assumed various committee roles following Mr. Raja Venkataraman's cessation. The update ensures continuity in board-level oversight and committee governance.

Amrutanjan Health Care Management Change

Amrutanjan Health Care announced the tenure completion of Independent Director Mr. Raja Venkataraman. This board departure follows the expiration of his scheduled appointment term.

Amrutanjan Health Care Annual General Meeting

Amrutanjan Health Care issued a Postal Ballot Notice for director appointments. Shareholders will vote via e-voting between May 19 and June 18, 2026.

Amrutanjan Health Care Annual General Meeting

Amrutanjan Health Care issued a postal ballot notice for appointing and re-appointing independent directors. Shareholders can vote via e-voting from May 19 to June 18, 2026.

Amrutanjan Health Care Financial Results

Amrutanjan reported a ₹57.92 Crore net profit for FY26. The board also recommended a final dividend of ₹2.90 per equity share for shareholders.

Value

₹57.92 Cr

Amrutanjan Health Care Earnings Call: Key Takeaways

Amrutanjan reported 11.23% revenue growth for FY26 with significant 37.2% jump in Q4 profit before exceptional items. Strategy focuses on power brands, distribution expansion, and digitization.

Amrutanjan Health Care Earnings Call: Key Takeaways

Amrutanjan reported FY26 net sales of ₹502.55 Cr (up 11.23%) and PAT of ₹57.92 Cr (up 13.95%). Strategy focuses on expanding Pain Management, Women's Hygiene, and new Personal Care categories.

Amrutanjan Health Care Employee Stock Options

Amrutanjan Health Care approved granting 2,00,000 stock options at ₹502.00 per share to 44 employees. The scheme involves a ₹10.04 Crore equity allocation over five years.

Value

₹10.04 Cr

Execution

5 years

Amrutanjan Health Care Management Change

Amrutanjan Health Care appointed Mr. Ramaswami Krishnan and re-appointed Mr. Muralidharan Swayambunathan as Independent Directors. Both appointments are for five-year terms, strengthening board governance.

Execution

5 years